ストックスクリーナーアプリを入手
74.40
2.03%
1.48
アフターアワーズ：
74.40
前日終値:
$72.92
開ける：
$74.5
24時間の取引高:
307.10K
Relative Volume:
0.33
時価総額：
$12.87B
収益：
$8.31B
当期純損益:
$379.00M
株価収益率:
34.44
EPS:
2.16
ネットキャッシュフロー:
$385.00M
1週間 パフォーマンス:
+1.88%
1か月 パフォーマンス:
+1.57%
6か月 パフォーマンス:
+1.09%
1年 パフォーマンス:
+31.36%
1日の値動き範囲:
$74.22
$74.64
1週間の範囲:
$72.11
$74.66
52週間の値動き範囲:
$54.26
$85.92
Solventum Corp Stock (SOLV) Company Profile
SOLV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
74.40 | 12.62B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
501.95 | 183.15B | 9.15B | 2.61B | 1.75B | 7.17 |
|
BDX
Becton Dickinson Co
|
182.58 | 51.96B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
92.22 | 43.85B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
273.37 | 39.21B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
227.31 | 15.73B | 2.90B | 467.20M | 306.90M | 6.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | アップグレード | Argus | Hold → Buy |
| 2025-06-06 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-10-08 | 開始されました | Stifel | Buy |
| 2024-10-07 | 開始されました | Piper Sandler | Neutral |
| 2024-09-26 | 開始されました | Wolfe Research | Peer Perform |
| 2024-09-05 | 開始されました | BTIG Research | Neutral |
| 2024-06-24 | 開始されました | Argus | Hold |
| 2024-05-30 | 開始されました | Goldman | Sell |
| 2024-05-10 | 開始されました | BofA Securities | Neutral |
| 2024-04-10 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-04-08 | 開始されました | Wells Fargo | Equal Weight |
| 2024-04-02 | 開始されました | Edward Jones | Hold |
すべてを表示
Solventum Corp (SOLV) 最新ニュース
Lobbying Update: $60,000 of SOLVENTUM lobbying was just disclosed - Quiver Quantitative
What analysts say about Solventum Corporation stockExtraordinary market timing - jammulinksnews.com
Solventum: Appealing Again (NYSE:SOLV) - Seeking Alpha
Is Solventum Corporation a good long term investmentExceptional growth trajectory - jammulinksnews.com
What drives Solventum Corporation stock priceOutstanding trading profits - jammulinksnews.com
Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review - MSN
Solventum Corporation Stock Analysis and ForecastHigh-performance investment picks - PrintWeekIndia
As more Minnesota companies rethink remote work, Solventum and others hold the line on flexibility - Star Tribune
Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025 - The Malaysian Reserve
Solventum To Report Second Quarter Fiscal 2025 Earnings On August 7, 2025 - Barchart.com
Steris, Solventum stocks upgraded at Morgan Stanley (STE:NYSE) - Seeking Alpha
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential By Investing.com - Investing.com South Africa
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential - Investing.com India
Morgan Stanley Upgrades Solventum to Overweight From Equalweight, Adjusts PT to $103 From $80 - MarketScreener
Thermo Fisher Wins EU Approval for Acquisition of Solventum's Filtration Business - MarketScreener
European Commission OKs Thermo Fisher's Purchase of Solventum's Purification, Filtration Arm - MarketScreener
Solventum Launches Two Dental Innovations in Thailand - MSN
Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know - MSN
Markets | American Financial Group, Inc. - FinancialContent
Solventum Corp. Stock Falls Tuesday, Underperforms Market - 富途牛牛
Solventum Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Solventum Corp (SOLV) Upgraded to a ‘Buy’ at Argus Research - Insider Monkey
Solventum (NYSE:SOLV) Has A Somewhat Strained Balance Sheet - simplywall.st
Is the Options Market Predicting a Spike in Solventum Stock? - MSN
Discussing the removal of dissolved gases from water with Solventum - watertechonline.com
Solventum Amends Thermo Fisher Deal, Retains Water Filtration Business - MSN
How Is Solventum's Stock Performance Compared to Other Health Care Equipment Stocks? - MSN
Solventum (NYSE:SOLV) Stock Rating Upgraded by Argus - MarketBeat
Solventum Shows Market Leadership With Jump To 83 RS Rating - MSN
Solventum's Strategic Shift Sparks Analyst Optimism Amid Diverging Price Targets - AInvest
Solventum Shares Rise After Argus Research Upgrade - MarketScreener
Argus Research Upgrades Solventum to Buy From Hold, $90 Price Target - MarketScreener
5 Must-Read Analyst Questions From Solventum’s Q1 Earnings Call - Yahoo Finance
How Is Solventum's Stock Performance Compared To Other Health Care Equipment Stocks? - Barchart.com
Bryan C. Hanson - Walgreens Boots Alliance
Solventum Named a Best Company to Work for by U.S. News & World Report - GuruFocus
How Did Solventum Corporation's (NYSE:SOLV) 12% ROE Fare Against The Industry? - Yahoo Finance
With 68% ownership, Solventum Corporation (NYSE:SOLV) boasts of strong institutional backing - simplywall.st
SOLV Q1 Earnings Call: Margin Headwinds Offset by Volume Growth and Product Momentum - Yahoo Finance
Solventum Corp (SOLV) 財務データ
収益
当期純利益
現金流量
EPS
0.48%
大文字化:
|
ボリューム (24 時間):